Scarica l'app Stockscreener
2.20
2.33%
0.05
Precedente Chiudi:
$2.15
Aprire:
$2.16
Volume 24 ore:
15,294
Relative Volume:
0.84
Capitalizzazione di mercato:
$22.38M
Reddito:
-
Utile/perdita netta:
$-17.93M
Rapporto P/E:
-0.9607
EPS:
-2.29
Flusso di cassa netto:
$-14.28M
1 W Prestazione:
+2.33%
1M Prestazione:
+4.76%
6M Prestazione:
+3.29%
1 anno Prestazione:
+47.65%
Intervallo 1D:
$2.06
$2.20
Intervallo di 1 settimana:
$1.99
$2.30
Portata 52W:
$1.325
$3.10
Cocrystal Pharma Inc Stock (COCP) Company Profile
Nome
Cocrystal Pharma Inc
Settore
Industria
Telefono
(786) 459-1831
Indirizzo
19805 N. CREEK PARKWAY, BOTHELL, WA
Confronta COCP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| COCP | 2.20 | 22.38M | 0 | -17.93M | -14.28M | -2.29 |
| VRTX | 450.97 | 116.14B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 738.00 | 81.10B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 605.92 | 36.23B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 113.13 | 27.12B | 3.30B | -501.07M | 1.03B | 11.54 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-07-08 | Iniziato | H.C. Wainwright | Buy |
Cocrystal Pharma Inc Borsa (COCP) Ultime notizie
Cocrystal Pharma (STU:8CC) 14-Day RSI : 67.70 (As of Nov. 20, 2024) - GuruFocus.com
Cocrystal Pharma (STU:8CC) GF Value Rank : 10 (As of Nov. 20, 2024) - GuruFocus.com
November 2024 US Exchange Standouts: Promising Penny Stocks - Yahoo Finance
Cocrystal Pharma (STU:8CC) 3-Year EPS without NRI Growth Ra - GuruFocus.com
Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs - The Manila Times
Cocrystal Pharma Advances Clinical Trials Despite $4.9M Q3 Loss, Key Results Expected | COCP Stock News - StockTitan
Cocrystal Pharma Advances Antiviral Drug Development - TipRanks
Cocrystal Pharma's Co-CEOs Highlight Pioneering Approach to Antiviral Drug Candidates Targeting Influenza and Coronaviruses as Fall Flu and COVID Season Begins - The Manila Times
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients' 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction - The Manila Times
Here's Why We're Watching Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Situation - Yahoo Finance
Pharmaceutical Grade Hydroxytyrosol Market Poised for Growth - openPR
Influenza Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - openPR
Seasonal Influenza Treatment Market Size, Treatment Drugs, and Companies 2024 - openPR
Cocrystal Pharma execs get pay raise and stock grants By Investing.com - Investing.com Canada
Cocrystal Pharma execs get pay raise and stock grants - Investing.com India
Cocrystal Pharma Boosts Executive and Director Compensation - TipRanks
Mira Pharmaceuticals (NASDAQ:MIRA) Stock Quotes, Forecast and News Summary - Benzinga
Cocrystal Pharma commences next phase of antiviral study - Investing.com
Cocrystal Pharma commences next phase of antiviral study By Investing.com - Investing.com Canada
Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose Cohorts - The Manila Times
Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose - EIN News
Seasonal Influenza Treatment Market Size in the 7MM was ~USD 9177 million in 2023, estimated DelveInsight - openPR
Corover Secures $4 Mn In Series A Funding Led By Venture Catalysts - BW Disrupt
K2 Principal Fund L.P. Takes $1.17 Million Position in CSLM Acquisition Corp. (NASDAQ:CSLM) - Defense World
Coherent Corp (COHR) rating reiterates by Needham - Knox Daily
Farallon Capital Management LLC Decreases Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Corcel shares drop as explorer raise funds and ups exposure in Angola - Proactive Investors USA
Cogent Communications Holdings, Inc. (NASDAQ:CCOI) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Corcel PLC Bolsters Angola Position with Increased Stake and Funding - TipRanks
Corcel (LON:CRCL) Trading 2.6% Higher - Defense World
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Purchased by Rhumbline Advisers - Defense World
Bearish block trade of CSPC PHARMA(01093) 768K shares at $4.94, $3.794M turnover - AASTOCKS.com
CorVel Co. (NASDAQ:CRVL) Shares Acquired by Kayne Anderson Rudnick Investment Management LLC - MarketBeat
Coherent (COHR) Soars 6.3%: Is Further Upside Left in the Stock? - Yahoo Finance
Momentum Is Driving Corning Stock Higher (NYSE:GLW) - Seeking Alpha
Corbus stock reiterates Outperform rating despite trial data - Investing.com
Cosmic CRF shares hit 5% upper circuit on Rs 127-crore order win; details - Business Standard
Coherent Corp (COHR)’s Market Momentum: Closing Strong at 80.98, Up 3.93 - The Dwinnex
Corning’s stock rises as it sticks to Q3 profit view - MarketWatch
COHR’s Wild Ride: Up 82.75% – What’s Next for COHR? - The InvestChronicle
Cogent Biosciences (NASDAQ:COGT) Stock Price Up 4.1% - Defense World
CorriXR Therapeutics Appoints Jill Castilla to Its Board of Directors - Morningstar
Commonwealth Equity Services LLC Has $996,000 Holdings in Compass Diversified (NYSE:CODI) - Defense World
Examining the Potential Price Growth of CoreCivic Inc (CXW) - Knox Daily
Coherent (NYSE:COHR) delivers shareholders stellar 135% return over 1 year, surging 6.3% in the last week alone - Yahoo Finance
Prepare Yourself for Liftoff: Coherent Corp (COHR) - SETE News
Coherent Corp (COHR) receives a Buy rating from Needham - Knox Daily
Hollyland Cosmo C2 Wireless Video System First Look - Newsshooter
State of New Jersey Common Pension Fund D Lowers Stock Holdings in Sea Limited (NYSE:SE) - Defense World
LPL Financial LLC Has $46.81 Million Stake in iShares Fallen Angels USD Bond ETF (NASDAQ:FALN) - Defense World
CoreCivic Inc [CXW] stock for 106,240 USD was sold by Carter, Cole G. - Knox Daily
Cocrystal Pharma Inc Azioni (COCP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.89%
2.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):